Older adults suffering from persistent depression may find relief from symptoms with rapid magnetic brain stimulation, but the full effects of treatment may take several weeks. A recent clinical trial published in the American Journal of Psychiatry found that this non-invasive technique produced measurable improvement in symptoms over three months. These delayed results suggest that older brains may simply need more time to adapt to treatment.
Major depressive disorder is a major public health challenge and is difficult to manage, especially in later life. Older adults have a high rate of recurrence of depression and are often resistant to standard drug treatments. Traditional antidepressants can also cause physical side effects that are particularly harsh on older biological systems. This leads physicians to seek alternative treatments that are safe and well tolerated by vulnerable patients.
One alternative is repetitive transcranial magnetic stimulation. This is a therapeutic procedure that uses targeted magnetic fields to stimulate specific nerve cells in the brain. This treatment involves placing an insulated electromagnetic coil directly onto the patient’s scalp. This specialized coil sends out painless magnetic pulses that pass through the skull and alter the internal electrical activity of the nerve tissue just beneath the surface. It is frequently utilized for psychiatric patients who do not respond to typical medications and psychotherapy.
A newer, streamlined version of this therapy is known as theta burst stimulation. This specialized magnetic method roughly mimics the human brain’s natural electrical rhythms, allowing therapists to deliver exactly the same amount of stimulation in a fraction of the time. While a standard magnetic session can last nearly 40 minutes, a theta burst session takes only a few minutes from start to finish. This brevity makes it easier for patients to adhere to their daily outpatient treatment schedule.
Although the U.S. Food and Drug Administration has approved several magnetic stimulation devices for the treatment of late-life depression, the actual clinical evidence for this particular age group remains somewhat vague. Previous systematic reviews have yielded mixed results regarding the overall effectiveness of this technique in older adults. Lead author Leandro da Costa Lane Variengo, a researcher at the University of São Paulo, and his colleagues designed a rigorous clinical trial to assess whether a shortened burst protocol could reliably reduce depressive symptoms in older patients.
The rigor of experimental recruitment was very high to ensure as accurate data as possible. Clinical evaluators initially screened more than 1,000 candidates from the general population and ultimately narrowed the field to 108 older adults. The average age of the selected participants was 67 years, and all were suffering from an active destructive moderate to severe depressive episode.
To ensure that therapeutic effects were produced solely by magnetic stimulation, participants were required to safely taper off their existing antidepressant medication before starting the study. This study design effectively isolates physical brain interventions for pure observation. However, this trial is slightly removed from typical medical practice for older patients, which typically combines magnetic stimulation with a continuous medication regimen.
Participants were randomly assigned to receive either an active stimulus or a convincing sham treatment known as a sham control. The researchers used an improved magnetic coil that looks and sounds exactly the same as the active version. The machine was also able to send small synchronized electrical zaps to the scalp to recreate the physical sensation of an actual magnetic pulse. This blinding protocol ensured that patients, clinical evaluators, and machine operators were completely unaware of who received the real treatment.
To find the right dose of magnetic energy for each person, technicians determined an individual’s resting motor threshold. This is the minimum magnetic strength required to cause a patient’s thumb to twitch involuntarily when the coil is held over the brain’s motor cortex. Once this personal biological baseline was confirmed, treatment intensity was dialed up to a level slightly stronger than that natural electrical threshold.
The intervention specifically focused on the dorsolateral prefrontal cortex, a brain region deeply involved in mood regulation and decision planning. Older medical theories suggest that depression is often characterized by a functional imbalance in activity between the left and right sides of this prefrontal cortex. To address this perceived imbalance, the active treatment group received consecutive sequences of two different stimulation patterns designed to alter both brain hemispheres during a single visit.
First, medical staff applied a continuous burst pattern to the right side of the head. This is clinically thought to calm overactive neural circuits. Immediately thereafter, they applied an intermittent burst pattern to the left side, aiming to stimulate dull neural activity. Each patient in the active group received a total of 3,600 magnetic pulses per day. The study consisted of 20 consecutive daily sessions, followed by three maintenance sessions spaced over a 2-month period.
Researchers tracked patients’ symptoms using a standardized clinical diagnostic tool, the Hamilton Depression Rating Scale. They initially hypothesized that by the sixth week of the trial, the active treatment would outperform the sham treatment. At that 6-week evaluation, the reduction in symptoms in the active treatment group was not statistically significant compared to the reduction seen in the sham treatment group. Both groups experienced a decrease in depression scores, a common psychological occurrence in trials using highly realistic placebos.
By week 12, a completely different pattern emerged in patient data. Patients who received active magnetic therapy showed a significant and sustained reduction in depressive symptoms. At this 3-month evaluation, 52 percent of the active group had a positive clinical response. This means that the severity of symptoms has decreased by at least half. In contrast, only 33% of people in the sham treatment group achieved a similar level of symptom relief.
Clinical researchers also assessed remission. Remission occurs when a patient’s score becomes so low that they are almost considered completely free of depression. In this particular trial, there was no statistical difference in remission rates between the two groups, ruling out mathematical chance. Still, the clear differences in overall response severity emphasized that clear biologic treatment benefits emerge at later stages of the trial.
Medical researchers suspect that this slow improvement reflects the biological reality of brain aging. Neuroplasticity is the brain’s innate ability to form new neural connections and reorganize its physical structure to overcome injury or disease. This ability to rebuild tends to decline with age. Because older brains may have a reduced capacity for rapid change, longer periods of cumulative stimulation may be required for the synaptic remodeling that ultimately leads to measurable mood improvements.
Intermittent booster sessions provided during the later weeks of the trial may also have played a role in guiding this delayed treatment response. Periodic magnetic stimulation could theoretically help strengthen newly established neural pathways. This physiological concept is consistent with other neurological studies suggesting that spaced maintenance therapy helps consolidate changes in brain networks over long periods of time.
Over a three-month period, this treatment proved to be surprisingly safe for this elderly population. The absolute most commonly reported side effects in both active and sham treatment groups were general headache and a temporary painful tingling sensation in the scalp during physical procedures. None of these adverse events differed in the frequency recorded between the two groups, officially confirming that the actual magnetic therapy did not cause any unique physiological harm.
Although the trial results offer general hope for older adults struggling with mental health, the study had some distinct limitations. The researchers utilized a traditional cephalometric system to properly position the magnetic coil on the patient’s head. They did not use advanced magnetic resonance imaging techniques to map and target the precise internal brain structures of individual patients. Although this generalized mapping technique makes the treatment accessible and affordable in standard clinics, it may reduce the final anatomical accuracy of the magnetic pulses.
The dual hemisphere treatment approach can also be considered a technical limitation. Some recent patient registry data suggest that stimulating just one side of the brain may actually have better results than bilateral treatment. Stimulating both hemispheres is rooted in an old concept of depression that is now being debated by modern neuroscientists. It is still quite possible that the continued burst on the right side inadvertently weakened the overall effectiveness of the experimental treatment.
Looking ahead, neuroscientists will need to refine these stimulation protocols to maximize symptom relief in older adults. Future research may test accelerated treatment schedules with multiple burst sessions per day, which may allow the aging brain to adapt more quickly. Researchers also need to determine the optimal number of magnetic pulses needed to induce reliable mood changes without overstimulating the target neural circuits.
The study, “Bilateral theta-burst stimulation of dorsolateral prefrontal cortex areas for late-life depression: A randomized sham-controlled clinical trial,” was authored by Leandro da Costa Lane Valiengo, Bianca Silva Pinto, Matthias Luethi, Leonardo Afonso Santos, Rafael Garcia Benatti, Míra Pinheiro Maux Lessa, and Julia. Cunha Loureiro, Jessica Formiga Silva, Lisian Martins, Pedro Sadobrac Oliveira, Bruna Baliani Teixeira, Luala Cristina Torto, Renata da Rocha Vaughan, Roberta de… Arruda Méndez Pereira Fiusa Dini Matar, Valkyria Aparecida da Silva, Wagner Farid Gattas, Frank Padberg, Orestes Vicente Forlenza, Andre Russowski Brunoni.
